| Literature DB >> 23396325 |
Sabiha Sahin1, Serdar Oter, Dilek Burukoğlu, Emine Sutken.
Abstract
BACKGROUND: To examine the effect of carnosine on liver function and histological findings in experimental septic shock model, 24 Sprague-Dawley rats were used. MATERIAL/Entities:
Mesh:
Substances:
Year: 2013 PMID: 23396325 PMCID: PMC3940703 DOI: 10.12659/msmbr.883758
Source DB: PubMed Journal: Med Sci Monit Basic Res ISSN: 2325-4394
Comparison of haematologic parameters and weights of rats.
| Control group | Group sepsis + carnosine | Group sepsis | p | |
|---|---|---|---|---|
| HB1 (g/dL) | 11.2625±1.11 | 11.6350±1.32 | 11.724±2.27 | p≥0.05 |
| HCT1 | 34.6500±3.56 | 34.4235±2.87 | 34.7206±3.14 | p≥0.05 |
| HB2 | 10. 812±0.789 | 10.912±0.780 | 10.898±0.987 | p≥0.05 |
| HCT2 | 32.21±1.28 | 31.56±2.26 | 32.13±1.06 | p≥0.05 |
| Weight (gram) | 252,134 | 261,165 | 258,373 | p≥0.05 |
Biochemical findings.
| Group | Median (25–75) | Multiple comparison results | |||
|---|---|---|---|---|---|
| Sepsis | Sepsis + carnosine | Control | |||
| AST1 serum (U/l) baseline | Sepsis | 35.12±6.87 (1204–8913) | ns | ns | ns |
| Sepsis + carnosine | 34.62±2.5 (50–5357) | ns | ns | ns | |
| Control | 37.5±5.63 (183–336) | ns | ns | ns | |
| H=0.995 DF=2 (P=0.608) | |||||
| AST2 (U/l) | Sepsis | 383.87±17.5 (420–3543) | |||
| Sepsis + carnosine | 119.5±11.3 (309–1575) | ||||
| Control | 50.37±9.55 (50–118) | ||||
| H=14.256 DF=2 | |||||
| ALT1 (U/l) baseline | Sepsis | 20.37±6.9 (3.20–7.66) | ns | ns | ns |
| Sepsis + carnosine | 20.62±6.25 (1.89–3.76) | ns | ns | ns | |
| Control | 21.5±4.1 (1.02–3.85) | ns | ns | ns | |
| H=1.540 D=2 (P=0.463) | |||||
| ALT2 (U/l) | Sepsis | 168.5±52.05 (10.8–26.7) | |||
| Sepsis + carnosine | 17.92±3.12 (6.98–8.34) | ||||
| Control | 6.78±1.92 (5.2–11.9) | ||||
| H=12.128 DF=2 | |||||
| MDAT nmol/g.pr | Sepsis | 20.23±1.94 (43.8–75.6) | |||
| Sepsis + carnosine | 12.28±0.75 (28.6–42.2) | ||||
| Control | 11.45±1.64 (10.2–11.9) | ||||
| H=11.752 DF=2 | |||||
| MDAS pg/ml | Sepsis | 7.78±1.42 (43.8–75.6) | |||
| Sepsis + carnosine | 3.8±0.74 (28.6–42.2) | ||||
| Control | 2.41±0.66 (10.2–11.9) | ||||
| H=17.956 DF=2 | |||||
ns – p>0.05;
p<0.05;
p<0.001;
H – Kruskal-Wallis.
Figure 1Control Group; Liver histology was normal in control animals (bar: 100 μm, HE).
Figure 2Treatment Group (septic shock + carnosine); Rats treated with carnosine exhibit a marked decrease in sinusoidal dilatation and cellular inflammation of the portal region, compared to rats with untreated septic shock (bar: 200 μm, bar: 100 μm, HE).
Figure 3Sepsis Group; Sinusoidal dilatations (dense arrow) (A, C), excessive cellular inflammation in portal region (arrow head) (B) and necrotic cell structures and hypertrophy in hepatocyte cell nucleus (arrow) (D) were remarkable rats exposed to septic shock by cecal ligation (bar: 100 μm, bar: 50.0 μm, bar: 20.0 μm, HE).
Histological evaluation findings of all groups at the end of the study.
| Liver | Necrosis | Sinusoidal Dilatation | Inflammation | Congestion |
|---|---|---|---|---|
| Control 1 | − | − | − | − |
| Control 2 | − | − | − | − |
| Control 3 | − | − | − | − |
| Control 4 | + | − | − | − |
| Control 5 | − | − | − | − |
| Control 6 | − | − | − | − |
| Control 7 | − | − | − | − |
| Control 8 | − | − | − | − |
| Sepsis 1 | +++ | +++ | ++ | − |
| Sepsis 2 | + | ++ | − | − |
| Sepsis 3 | − | ++ | − | + |
| Sepsis 4 | ++ | − | +++ | − |
| Sepsis 5 | ++ | + | − | + |
| Sepsis 6 | − | + | ++ | − |
| Sepsis 7 | + | − | + | − |
| Sepsis 8 | +− | +++ | − | ++ |
| Sepsis + carnosine 1 | − | − | − | − |
| Sepsis + carnosine 2 | − | − | + | + |
| Sepsis + carnosine 3 | − | − | + | − |
| Sepsis + carnosine 4 | − | + | + | − |
| Sepsis + carnosine 5 | − | − | + | − |
| Sepsis + carnosine 6 | − | − | − | − |
| Sepsis + carnosine 7 | − | − | + | − |
| Sepsis + carnosine 8 | − | − | − | − |
Histological findings: absent (−); mild (+); moderate (++); severe (+++).
Histological results.
| Groups | Median (25–75) | Multiple Comparison Results | |||
|---|---|---|---|---|---|
| Sepsis | Sepsis + carnosine | Control | |||
| Necrosis | Sepsis | 3.000 (1.5–3.0) | |||
| Sepsis + carnosine | 1.500 (1.0–2.0) | ns | |||
| Control | 0.00 (0.0-0.0) | ns | |||
| H=12.806 DF=2 P=0.012 | |||||
| Congestion | Sepsis | 2.500 (1.5–3.0) | |||
| Sepsis + carnosine | 1.000 (1.0–2.0) | ||||
| Control | 0.000 (0.0-0.0) | ||||
| H=12.845 DF=2 P=0.059 | |||||
| Sinusoidal dilatation | Sepsis | 3.000 (3.0-3.0) | |||
| Sepsis + carnosine | 2.000 (2.0-3.0) | ||||
| Control | 0.000 (0.0-0.0) | ||||
| H=14.62 DF=2 P=0.018 | |||||
| Inflammation (PNL) | Sepsis | 3.000 (3.0-3.0) | |||
| Sepsis + carnosine | 1.000 (2.0-2.0) | ||||
| Control | 0.000 (0.0-0.0) | ||||
| H=14.82 DF=2 P=0.036 | |||||
n – p>0.05;
p<0.05;
p<0.001;
H – Kruskal-Wallis.